T0	Outcomes 168 211	relative efficacy and technical ease of use
T1	Outcomes 1067 1188	immediate efficacy, low volume requirement, time required for initial hemostasis, and reduction of gastric variceal size.
T2	Outcomes 1189 1239	Cyanoacrylate, tetradecyl sulfate, and polidocanol
T3	Outcomes 1349 1378	induced or secondary bleeding